Evidence map›Paper›PMID 37435980›Full record

ArticleCell proliferation2023

Suppression of SLC39A6-CREB1 axis in liver cancer causes PCK1-mediated mitochondrial dysfunction.

Ze Yu, Cheng Chen, Hongpeng Gu, Jinliang Dong, Yingjie Zhang, Jie Wang, Haijie Ma, Guoqiang Zhang

Open access · goldAbstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Cell proliferation, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.0field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Silencing ofActa biochimica et biophysica Sinica · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Ze YuDepartment of General Surgery, Zhoushan Hospital, Wenzhou Medical University, Zhoushan, Zhejiang, China.ORCID 0000-0002-5849-3413
Cheng ChenDepartment of Oncology, Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Science, Xiangyang, Hubei, China.
Hongpeng GuDepartment of General Surgery, Zhoushan Hospital, Zhejiang University School of Medicine, Zhoushan, Zhejiang, China.
Jinliang DongDepartment of General Surgery, Zhoushan Hospital, Wenzhou Medical University, Zhoushan, Zhejiang, China.
Yingjie ZhangDepartment of General Surgery, Zhoushan Hospital, Wenzhou Medical University, Zhoushan, Zhejiang, China.
Jie WangThe Laboratory of Cytobiology and Molecular Biology, Zhoushan Hospital, Wenzhou Medical University, Zhoushan, Zhejiang, China.
Haijie MaThe Laboratory of Cytobiology and Molecular Biology, Zhoushan Hospital, Wenzhou Medical University, Zhoushan, Zhejiang, China.
Guoqiang ZhangDepartment of General Surgery, Zhoushan Hospital, Wenzhou Medical University, Zhoushan, Zhejiang, China.
Wenzhou Medical University · CNHubei University of Arts and Science · CNZhoushan Hospital · CN

Funding

China Postdoctoral Science Foundation 2020M680120
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Cation Transport ProteinsLiver NeoplasmsCyclic AMP Response Element-Binding ProteinHumansIntracellular Signaling Peptides and ProteinsMitochondriaNeoplasm ProteinsPhosphoenolpyruvate Carboxykinase (GTP)Cation Transport ProteinsCREB1 protein, humanCyclic AMP Response Element-Binding ProteinIntracellular Signaling Peptides and ProteinsNeoplasm ProteinsPCK1 protein, humanPhosphoenolpyruvate Carboxykinase (GTP)SLC39A6 protein, human

Identifiers

PMID37435980
PMCPMC10542647
OpenAlexW4383998032

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.